Log in to your Inderes Free account to see all free content on this page.

Ambu

121.45

DKK

-3.15 %

Less than 1K followers

AMBU B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

-3.15%

-9.09%

+16.78%

+9.86%

-4.93%

-0.21%

+10.26%

-15.04%

+12,518.18%

Ambu is active in medical technology. The company develops and markets diagnostic equipment for actors in healthcare. The largest activity is found in the development of solutions for endoscopy, gastroscopy and patient monitoring. Operations are held on a global level with the largest presence in Europe and North America. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark.

Market cap

32.71B DKK

Turnover

45.79M DKK

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

7.5.

2025

Interim report Q2'25

22.8.

2025

Interim report Q3'25

5.11.

2025

Annual report '25

ShowingAll content types

Regulatory press release1/31/2025, 8:35 AM

Launch of Long-Term Incentive Plan for Executive Management and key employees

Regulatory press release1/30/2025, 6:00 AM

INTERIM REPORT FOR Q1 2024/25

Regulatory press release1/9/2025, 5:28 PM

AMBU RAISES FINANCIAL OUTLOOK FOR 2024/25

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release12/4/2024, 3:18 PM

DECISIONS OF THE ANNUAL GENERAL MEETING OF AMBU A/S

Regulatory press release12/3/2024, 2:29 PM

Reporting of transactions made by persons discharging managerial responsibilities

Regulatory press release11/22/2024, 3:02 PM

Reporting of transactions made by persons discharging managerial responsibilities

Regulatory press release11/22/2024, 3:00 PM

Reporting of transactions made by persons dischargingmanagerial responsibilities

Regulatory press release11/8/2024, 11:15 AM

NOTICE OF THE ANNUAL GENERAL MEETING 2024 OF AMBU A/S

Regulatory press release11/7/2024, 3:44 PM

Reporting of transactions made by persons discharging managerial responsibilities

Regulatory press release11/5/2024, 6:00 AM

ANNUAL REPORT 2023/24

Regulatory press release11/4/2024, 5:15 PM

INTERIM REPORT FOR Q4 AND THE FULL-YEAR 2023/24 RESULTS (UNAUDITED)

Regulatory press release11/4/2024, 5:02 PM

AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2024/25 FINANCIAL YEAR

Regulatory press release9/30/2024, 11:08 AM

AMBU FINANCIAL CALENDAR FOR 2024/25

Regulatory press release9/2/2024, 10:17 AM

Major shareholder announcements

Regulatory press release8/30/2024, 5:00 AM

INTERIM REPORT FOR Q3 2023/24

Regulatory press release7/10/2024, 5:33 PM

AMBU INCREASES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR

Regulatory press release5/14/2024, 5:00 AM

INTERIM REPORT FOR Q2 2023/24 AND THE HALF-YEAR

Regulatory press release4/10/2024, 7:27 PM

AMBU RAISES OUTLOOK FOR THE 2023/24 FINANCIAL YEAR

Regulatory press release2/9/2024, 3:45 PM

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

Regulatory press release2/6/2024, 1:40 PM

GRANT OF PERFORMANCE SHARE UNITS

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.